Skip to main content
Clinical Trials/NCT00484133
NCT00484133
Unknown
Phase 4

Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis

Onze Lieve Vrouwe Gasthuis1 site in 1 country80 target enrollmentJune 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Severe Sepsis
Sponsor
Onze Lieve Vrouwe Gasthuis
Enrollment
80
Locations
1
Primary Endpoint
Difference in SOFA (Sequential Organ Failure Assessment) score during the first 72 hours of treatment for severe sepsis
Last Updated
18 years ago

Overview

Brief Summary

The purpose of this study is to asses the recovery of organ failure between two resuscitation protocols in severe sepsis: standard, pressure guided therapy versus a microcirculation guided therapy

Detailed Description

Despite continued improvements in medical therapy, mortality from septic shock has remained between 30% and 70% for the past three decades with only a slight decrease in mortality rate. Standard treatment of septic shock is fluid resuscitation, followed by agents with vasopressor activity to correct hypotension in septic shock. The question rises whether vasopressors should be the first line of action in septic shock Opening and recruiting the microcirculation are expected to improve regional organ function and tissue distress in severe sepsis. Beside fluid resuscitation, vasodilatation, in this respect, enhances microcirculatory flow while vasoconstriction causes a reduction in microcirculatory flow. On the other hand, a minimal perfusion pressure should be present. Our aim is to asses the effects of two resuscitation protocols in severe sepsis: the "standard treatment" using predefined pressure goals versus a microcirculation guided therapy.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
December 2008
Last Updated
18 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Onze Lieve Vrouwe Gasthuis

Eligibility Criteria

Inclusion Criteria

  • age 18 years or older
  • admission to the intensive care unit with severe sepsis, defined in according with a modification of the American College of Chest Physician/SCCM guidelines criteria
  • intention to provide full intensive care treatment for at least 72 hours and
  • written informed consent to be obtained from patient or next of kin.

Exclusion Criteria

  • haematologic malignancy
  • metastatic malignancy
  • AIDS with CD4 \< 50 cells/mm3
  • liver cirrhosis Child Pugh B \& C
  • pregnancy
  • post resuscitation with GCS \< 8 of 15 and treatment with induced hypothermia

Outcomes

Primary Outcomes

Difference in SOFA (Sequential Organ Failure Assessment) score during the first 72 hours of treatment for severe sepsis

Time Frame: 72 hours

Secondary Outcomes

  • ICU and hospital length of stay(hospital stay)
  • Severity, decrease and duration of organ failure over the complete ICU stay(complete icu stay)
  • Duration of organ support(during ICU treatment)
  • ICU and hospital mortality(hospital stay)
  • Plasma concentration of asymmetric dimethyl arginine (ADMA(72 hours)
  • Inflammatory response measured by IL-6/IL-10(72 hours)

Study Sites (1)

Loading locations...

Similar Trials